(781)843-5491 [email protected]
  • Facebook
  • Twitter
  • LinkedIn
  • Facebook
  • Twitter
  • LinkedIn
  • Contact
MVG Consulting Services
  • Services and Capabilities
    • Clinical Development
      • Clinical Development Programs
        • Pre-Study
        • Ongoing Studies
        • Marketing Applications
        • Clinical Operations
        • Clinical Project Management
      • Project Rescue
      • Clinical Study Support
      • Data Management
      • Medical Writing
      • Trial Master File (TMF) and eTMF Management
    • Inspection Readiness
    • Quality Assurance
      • Auditing
      • Gap Analysis and Remediation
      • Clinical Quality Systems
        • SOP Development
        • Internal Training
      • Customized QA Consulting
      • Computer System Validation
    • REMS Project Management
    • CRO Alternative
      • Hybrid Model
      • Managed CRO
      • CRO Remediation
  • About MVG
    • Why MVG
    • Our Team
  • MVG Insights
    • Case Studies
    • Blog/Newsletters
Select Page

Post COVID-19 Clinical Trials Will Never Be The Same

by MVG Consulting | May 26, 2020 | Industry News

Prior to the massive changes and limitations brought forth by the outbreak of COVID-19, clinical trials had an outdated approach to many of their processes, with effects extending through development phases, the collection of patient data, regulatory processes and...

Patients, drug makers grapple with cancer clinical trials during coronavirus

by MVG Consulting | May 18, 2020 | Featured, Industry News

With increased limitation in the capacity to develop, plan, and execute regulation-abiding clinical trials, there is growing concern surrounding the best tactics to proceed forward.   The coronavirus pandemic has thrown a wrench into plans for hundreds of...

COVID-19 Beckons a New Area for Clinical Trials

by MVG Consulting | May 13, 2020 | Clinical Trials, Industry News

  When the effects of COVID-19 took root in the US, a shift away from typical routines was triggered, one which brought far reaching repercussions. In all areas of life, this pandemic has forced change, no matter the feasibility of adapting to such change. Where...

Recent Posts

  • Newly Approved REMS Programs 2025 and Evolving Trends
  • Draft FDA Guidance – Protocol Deviations
  • Guideline for Good Clinical Practice – Key Changes in ICH E6 R3
  • Celebrating 25 Years of MVG Consulting!
  • The Evolution of FDA Recommendations on Real World Evidence and Real World Data

Categories

  • Clinical Trials
  • Company News
  • Featured
  • Industry News
  • Instagram

Archives

  • April 2025
  • March 2025
  • February 2025
  • August 2023
  • August 2022
  • February 2022
  • January 2022
  • September 2021
  • August 2021
  • July 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018

MVG Consulting Services Inc.  •  400 Washington Street | Suite 403, Braintree MA 02184  •  Phone: (781)843-5491  •  Fax: 781.843.3087  •  EMail: [email protected]

Website by Nisse Designs   |   ©2025 MVG Consulting Services Inc.